|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US20030026782A1
(en)
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6825174B2
(en)
*
|
1995-06-07 |
2004-11-30 |
East Carolina University |
Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation
|
|
US6025339A
(en)
*
|
1995-06-07 |
2000-02-15 |
East Carolina University |
Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation
|
|
US6040296A
(en)
*
|
1995-06-07 |
2000-03-21 |
East Carolina University |
Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation
|
|
US7034007B1
(en)
|
1995-06-07 |
2006-04-25 |
East Carolina University |
Low adenosine anti-sense oligonucleotide, compositions, kit & method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) & surfactant depletion
|
|
US6214806B1
(en)
*
|
1997-02-28 |
2001-04-10 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders
|
|
GB9718487D0
(en)
*
|
1997-09-02 |
1997-11-05 |
Univ Sheffield |
Pulmonary hypertension
|
|
BR9812650A
(pt)
*
|
1997-09-17 |
2000-08-22 |
Univ East Carolina |
ácidos nucléicos hibridizando marcação múltipla, preparação dos mesmos, composições, formulação, kits e aplicações
|
|
CA2248762A1
(en)
*
|
1997-10-22 |
1999-04-22 |
University Technologies International, Inc. |
Antisense oligodeoxynucleotides regulating expression of tnf-.alpha.
|
|
WO1999028474A2
(en)
*
|
1997-12-01 |
1999-06-10 |
The Government Of The United States Of America, Represented By The Secretary Of Health And Human Services |
Chemokine variants and methods of use
|
|
US6121023A
(en)
*
|
1998-01-22 |
2000-09-19 |
Akzo Nobel N.V. |
Isothermal transcription based assay for the detection and quantification of the chemokine rantes
|
|
US6525185B1
(en)
|
1998-05-07 |
2003-02-25 |
Affymetrix, Inc. |
Polymorphisms associated with hypertension
|
|
DE69932717T2
(de)
|
1998-05-22 |
2007-08-09 |
Ottawa Health Research Institute, Ottawa |
Methoden und produkte zur induzierung mukosaler immunität
|
|
EP1011608A4
(en)
*
|
1998-06-08 |
2002-05-15 |
Epigenesis Pharmaceuticals Inc |
COMPOSITION AND METHOD FOR THE PREVENTION AND TREATMENT OF HEART AND NEUTRAL FAILURE OR DAMAGE RELATED TO ISCHEMIA, ENDOTOXIN RELEASE, ARDS OR CALLED BY THE ADDITION OF SPECIFIC MEDICINES
|
|
US7244714B1
(en)
*
|
1998-06-12 |
2007-07-17 |
Aradigm Corporation |
Methods of delivering aerosolized polynucleotides to the respiratory tract
|
|
CA2333901A1
(en)
*
|
1998-08-03 |
2000-02-24 |
East Carolina University |
Low adenosine anti-sense oligonucleotide agent, composition, kit and treatments
|
|
US6228642B1
(en)
*
|
1998-10-05 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression
|
|
US6080580A
(en)
*
|
1998-10-05 |
2000-06-27 |
Isis Pharmaceuticals Inc. |
Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression
|
|
EP1165093A4
(en)
*
|
1999-03-05 |
2002-07-24 |
Epigenesis Pharmaceuticals Inc |
METHOD FOR VALIDATION / DECLARATION OF GOALS AND WAYS
|
|
US6136603A
(en)
*
|
1999-03-26 |
2000-10-24 |
Isis Pharmaceuticals Inc. |
Antisense modulation of interleukin-5 signal transduction
|
|
JP2003515525A
(ja)
*
|
1999-04-06 |
2003-05-07 |
イースト カロライナ ユニバーシティ |
気管支収縮、肺炎、アレルギーおよびサーファクタント枯渇と関連する気道障害を治療するための、低アデノシンアンチセンスオリゴヌクレオチド、その組成物、キットならびにその方法
|
|
AU6336000A
(en)
*
|
1999-06-17 |
2001-01-09 |
Eastern Virginia Medical School |
Treatment of viral influenza with antisense oligonucleotides
|
|
US7585847B2
(en)
*
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
WO2002081628A2
(en)
*
|
2001-04-05 |
2002-10-17 |
Ribozyme Pharmaceuticals, Incorporated |
Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
|
|
WO2002085308A2
(en)
*
|
2001-04-24 |
2002-10-31 |
Epigenesis Pharmaceuticals, Inc. |
Antisense and anti-inflammatory based compositions to treat respiratory disorders
|
|
US20090247606A1
(en)
*
|
2001-08-28 |
2009-10-01 |
Sirna Therapeutics, Inc. |
RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
|
|
US20030099668A1
(en)
|
2001-09-14 |
2003-05-29 |
Cytos Biotechnology Ag |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
JP2006512927A
(ja)
|
2002-12-11 |
2006-04-20 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
５’ｃｐｇ核酸およびその使用方法
|
|
FR2848573B1
(fr)
*
|
2002-12-13 |
2005-04-08 |
Exonhit Therapeutics Sa |
Compositions et methodes pour la detection et le traitement de pathologies neurodegeneratives
|
|
EP1618131A2
(en)
|
2003-04-15 |
2006-01-25 |
Xenon Pharmaceuticals Inc. |
Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof
|
|
AU2006216514C1
(en)
|
2005-02-25 |
2012-09-27 |
Isis Pharmaceuticals, Inc. |
Compositions and their uses directed to IL-4R alpha
|
|
US20070184068A1
(en)
|
2005-12-14 |
2007-08-09 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
|
EP2530086B1
(en)
|
2006-06-12 |
2019-03-20 |
Kuros Biosciences AG |
Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
|
|
US8202848B2
(en)
*
|
2008-03-17 |
2012-06-19 |
Board Of Regents, The University Of Texas System |
Identification of micro-RNAS involved in neuromuscular synapse maintenance and regeneration
|
|
US9399125B2
(en)
|
2013-02-13 |
2016-07-26 |
Becton, Dickinson And Company |
Needleless connector and access port disinfection cleaner and antimicrobial protection cap
|